Jacqueline Corrigan-Curay
Dr. Jacqueline Corrigan-Curay is a prominent figure in the field of pharmaceuticals, serving as a key official at the U.S. Food and Drug Administration (FDA). She has played a significant role in regulating and approving new medications, including innovative pain relief drugs. Recently, she was in the news for her comments on the approval of Journavx, a non-opioid pain relief medication, which is considered a landmark development in the effort to combat the opioid crisis in the United States.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Vietnam | 1 | 8.00 | 0.10% | +0% | 97,338,583 | 97,339 | $340,000 | 340$ |
| Totals | 1 | 97,338,583 | 97,339 | $340,000 | 340$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Vietnam:
Jacqueline Corrigan-Curay from the FDA described the approval of Journavx as a public health milestone.
8